A Single-Center Investigator-Initiated Evaluator-Bilateral-Comparison Pilot Study of Injectable Calcium Hydroxylapatite With and Without Triamcinolone Acetate for the Treatment of Volume Loss to Dorsum Areas of the Hands
Sponsor: Goldman, Butterwick, Fitzpatrick and Groff
A NA clinical study on Volume Loss to Dorsum of Hands, this trial is completed. The trial is conducted by Goldman, Butterwick, Fitzpatrick and Groff and has accumulated 8 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Feb 2018 — Jun 2018 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Mar 2017 — Feb 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed · Phase: PHASE4 → NA
-
Feb 2017 — Mar 2017 [monthly]
Active Not Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Goldman, Butterwick, Fitzpatrick and Groff
- Merz North America, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .